Health

What Is Hemophilia? Symptoms, Causes, Diagnosis, and Treatment

It’s common for people who have or have had family members with hemophilia to get their baby boys tested for the condition shortly after they’re born. About one-third of babies who have hemophilia have no relatives with the disorder, so infants may be evaluated if they show symptoms.

Ideally, testing is planned before the baby’s birth so that a blood sample can be drawn from the umbilical cord. Umbilical cord blood testing is better at discovering low levels of factor 8 than at finding low levels of factor 9, because factor 9 levels are not at a normal level until a baby is at least 6 months old.

Two types of tests are used for diagnosis: screening tests and clotting factor tests, which are also called factor assays.

Screening Tests

Screening tests are blood tests that reveal whether the blood is clotting properly. There are several types of screening tests for hemophilia:

Complete Blood Count (CBC) This test measures the amount of hemoglobin (the red pigment inside red blood cells that carries oxygen), the percentage of blood volume occupied by red blood cells (called the hematocrit), the size and amount of red blood cells, and the amounts of white blood cells and platelets in the blood. The CBC is normal in people with hemophilia, but if you have hemophilia and you have unusually heavy bleeding or bleed for a long period of time, the hemoglobin and the hematocrit can be low.

Activated Partial Thromboplastin Time (APTT) Test This test reveals how much time it takes for blood to clot; specifically, it measures the clotting ability of factors 8, 9, 11, and 12. If any of these clotting factors are diminished, it takes longer than normal for the blood to clot. The results of the APTT test will show a longer clotting time if you have hemophilia A or B.

Prothrombin Time (PT) Test This test also reveals how long it takes for blood to clot. It focuses on the clotting ability of factors 1, 2, 5, 7, and 10. If any of these factors are in short supply, it takes longer for the blood to clot. Most people with hemophilia A and B will have normal results on this test.

Fibrinogen Test This test also reveals how well a person can form a blood clot. Fibrinogen is also known as clotting factor 1.

Clotting Factor Tests

Clotting factor tests, which are required to diagnose a bleeding disorder, reveal the type of hemophilia and how severe it is. They check the levels of factor 8 or factor 9 in the blood, and show whether you have mild, moderate, or severe hemophilia.

How Hemophilia C Is Diagnosed

Hemophilia C can be diagnosed via genetic testing.

Prognosis of Hemophilia

People with hemophilia are likely to have a relatively normal life expectancy and quality of life if they receive the treatment that they need and are knowledgeable about their condition.

Some people with hemophilia develop inhibitors, which are antibodies that the immune system creates to attack the clotting factors in hemophilia treatment.

 This happens when the body mistakes the clotting factors in the treatment for foreign intruders. Inhibitors can negatively affect the course of hemophilia, but new medications are currently being developed.

Around 60 to 70 percent of people with hemophilia A have severe hemophilia, and about 15 percent have moderate hemophilia.

The rest have a mild form of the condition.

Acquired hemophilia often goes away with treatment.


Source link

Related Articles

Back to top button